The implications of hyperoxia, type 1 diabetes and sex on cardiovascular physiology in mice

被引:5
作者
Bojkovic, Katarina [1 ]
Rodgers, Jennifer Leigh [1 ]
Vichare, Riddhi [1 ]
Nandi, Asmita [1 ]
Mansour, Hussein [1 ]
Saleem, Faizan [1 ]
Ul Abidin, Zain [1 ]
Vanthenapalli, Sahit [1 ]
Cheng, Feng [1 ]
Panguluri, Siva Kumar [1 ]
机构
[1] Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, 12901 Bruce B Downs Blvd,MDC 30, Tampa, FL 33612 USA
关键词
INDUCED HYPERTROPHY; LUNG INJURY; TESTOSTERONE; MORTALITY; DISEASE; SPERMATOGENESIS; CARDIOTOXICITY; CELLS;
D O I
10.1038/s41598-021-02550-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oxygen supplementation, although a cornerstone of emergency and cardiovascular medicine, often results in hyperoxia, a condition characterized by excessive tissue oxygen which results in adverse cardiac remodeling and subsequent injurious effects to physiological function. Cardiac remodeling is further influenced by various risk factors, including pre-existing conditions and sex. Thus, the purpose of this experiment was to investigate cardiac remodeling in Type I Diabetic (Akita) mice subjected to hyperoxic treatment. Overall, we demonstrated that Akita mice experience distinct challenges from wild type (WT) mice. Specifically, Akita males at both normoxia and hyperoxia showed significant decreases in body and heart weights, prolonged PR, QRS, and QTc intervals, and reduced %EF and %FS at normoxia compared to WT controls. Moreover, Akita males largely resemble female mice (both WT and Akita) with regards to the parameters studied. Finally, statistical analysis revealed hyperoxia to have the greatest influence on cardiac pathophysiology, followed by sex, and finally genotype. Taken together, our data suggest that Type I diabetic patients may have distinct cardiac pathophysiology under hyperoxia compared to uncomplicated patients, with males being at high risk. These findings can be used to enhance provision of care in ICU patients with Type I diabetes as a comorbid condition.
引用
收藏
页数:12
相关论文
共 50 条
[31]   Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes [J].
Wiviott, S. D. ;
Raz, I. ;
Bonaca, M. P. ;
Mosenzon, O. ;
Kato, E. T. ;
Cahn, A. ;
Silverman, M. G. ;
Zelniker, T. A. ;
Kuder, J. F. ;
Murphy, S. A. ;
Bhatt, D. L. ;
Leiter, L. A. ;
McGuire, D. K. ;
Wilding, J. P. H. ;
Ruff, C. T. ;
Gause-Nilsson, I. A. M. ;
Fredriksson, M. ;
Johansson, P. A. ;
Langkilde, A-M. ;
Sabatine, M. S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (04) :347-357
[32]   Adiponectin, type 2 diabetes and cardiovascular risk [J].
Lindberg, Soren ;
Jensen, Jan Skov ;
Bjerre, Mette ;
Pedersen, Sune H. ;
Frystyk, Jan ;
Flyvbjerg, Allan ;
Galatius, Soren ;
Jeppesen, Jorgen ;
Mogelvang, Rasmus .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2015, 22 (03) :276-283
[33]   Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes [J].
Cannon, Christopher P. ;
Pratley, Richard ;
Dagogo-Jack, Samuel ;
Mancuso, James ;
Huyck, Susan ;
Masiukiewicz, Urszula ;
Charbonnel, Bernard ;
Frederich, Robert ;
Gallo, Silvina ;
Cosentino, Francesco ;
Shih, Weichung J. ;
Gantz, Ira ;
Terra, Steven G. ;
Cherney, David Z. I. ;
McGuire, Darren K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1425-1435
[34]   Sex-dependent effects of Canagliflozin on kidney protection in mice with combined hypertension-type 1 diabetes [J].
Trentin-Sonoda, Mayra ;
Cheff, Veronique ;
Gutsol, Alex ;
Hebert, Richard L. .
PLOS ONE, 2023, 18 (12)
[35]   Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials [J].
Hinnen, Deborah ;
Kruger, Davida F. .
DIABETES METABOLIC SYNDROME AND OBESITY, 2019, 12 :447-454
[36]   Cardiovascular risk prediction in adults with type 1 diabetes: The Fremantle Diabetes Study [J].
Davis, Wendy A. ;
Davis, Timothy M. E. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (03) :E75-E78
[37]   A comparative study of cardiovascular risk stratification methods in type 1 diabetes mellitus patients [J].
de Araujo, Fabiano Malard ;
Comim, Fabio Vasconcellos ;
Lamounier, Rodrigo N. ;
Pena, Natalia F. ;
Fajardo, Virginia C. ;
de Faria, Regina Bicalho G. ;
Silva, Yuri M. ;
Lauria, Marcio Weissheimer .
DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01)
[38]   Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines [J].
Varkevisser, Rita Delphine Maiko ;
Birnie, Erwin ;
Vollenbrock, Charlotte E. ;
Mul, Dick ;
van Dijk, Peter R. ;
van der Klauw, Melanie M. ;
Veeze, Henk ;
Wolffenbuttel, Bruce H. R. ;
Aanstoot, Henk-Jan .
BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (04)
[39]   Influence of cardiovascular autonomic neuropathy on atherogenesis and heart function in patients with Type 1 diabetes [J].
Lacigova, Silvie ;
Bartunek, Lubos ;
Cechurova, Daniela ;
Visek, Jakub ;
Gruberova, Jitka ;
Krcma, Michal ;
Jankovec, Zdenek ;
Rusavy, Zdenek ;
Zourek, Michal .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) :26-31
[40]   Excess Cardiovascular Risk in Type 1 Diabetes Mellitus Role for a Dysfunctional Immune Response? [J].
Petrie, John R. ;
Sattar, Naveed .
CIRCULATION, 2019, 139 (06) :744-747